Disease activity status before and after COVID-19 vaccination among IIM (patient self-reported)
| Disease activity . | Before first dose of vaccine, n (%) . | After second dose of vaccine, n (%) . | OR (95% CI)a . | P . |
|---|---|---|---|---|
| Overall active disease | 722 (75.5) | 739 (77.3) | 0.108 | |
| Disease was inactive/remission | 163 (17.0) | 136 (14.2) | 0.108 | |
| Disease was active and worsening | 170 (17.7) | 209 (21.8) | 1.2 (1.03, 1.6) | 0.025 |
| Disease was active but stable | 504 (52.7) | 471 (49.2) | 0.131 | |
| Disease was active and improving | 48 (5.0) | 59 (6.1) | 0.274 | |
| I am not sure | 71 (7.4) | 82 (8.5) | 0.352 |
| Disease activity . | Before first dose of vaccine, n (%) . | After second dose of vaccine, n (%) . | OR (95% CI)a . | P . |
|---|---|---|---|---|
| Overall active disease | 722 (75.5) | 739 (77.3) | 0.108 | |
| Disease was inactive/remission | 163 (17.0) | 136 (14.2) | 0.108 | |
| Disease was active and worsening | 170 (17.7) | 209 (21.8) | 1.2 (1.03, 1.6) | 0.025 |
| Disease was active but stable | 504 (52.7) | 471 (49.2) | 0.131 | |
| Disease was active and improving | 48 (5.0) | 59 (6.1) | 0.274 | |
| I am not sure | 71 (7.4) | 82 (8.5) | 0.352 |
OR of disease activity status after second dose of vaccine compared with before first dose of vaccine. Those who responded by multiple responses were excluded from the analysis in this table (n = 136 before first dose vaccine and n = 219 after second vaccine dose were excluded). COVID-19: coronavirus disease 2019; IIM: idiopathic inflammatory myopathies; OR: odds ratio. BOLD text: statistically significant (P < 0.05).
Disease activity status before and after COVID-19 vaccination among IIM (patient self-reported)
| Disease activity . | Before first dose of vaccine, n (%) . | After second dose of vaccine, n (%) . | OR (95% CI)a . | P . |
|---|---|---|---|---|
| Overall active disease | 722 (75.5) | 739 (77.3) | 0.108 | |
| Disease was inactive/remission | 163 (17.0) | 136 (14.2) | 0.108 | |
| Disease was active and worsening | 170 (17.7) | 209 (21.8) | 1.2 (1.03, 1.6) | 0.025 |
| Disease was active but stable | 504 (52.7) | 471 (49.2) | 0.131 | |
| Disease was active and improving | 48 (5.0) | 59 (6.1) | 0.274 | |
| I am not sure | 71 (7.4) | 82 (8.5) | 0.352 |
| Disease activity . | Before first dose of vaccine, n (%) . | After second dose of vaccine, n (%) . | OR (95% CI)a . | P . |
|---|---|---|---|---|
| Overall active disease | 722 (75.5) | 739 (77.3) | 0.108 | |
| Disease was inactive/remission | 163 (17.0) | 136 (14.2) | 0.108 | |
| Disease was active and worsening | 170 (17.7) | 209 (21.8) | 1.2 (1.03, 1.6) | 0.025 |
| Disease was active but stable | 504 (52.7) | 471 (49.2) | 0.131 | |
| Disease was active and improving | 48 (5.0) | 59 (6.1) | 0.274 | |
| I am not sure | 71 (7.4) | 82 (8.5) | 0.352 |
OR of disease activity status after second dose of vaccine compared with before first dose of vaccine. Those who responded by multiple responses were excluded from the analysis in this table (n = 136 before first dose vaccine and n = 219 after second vaccine dose were excluded). COVID-19: coronavirus disease 2019; IIM: idiopathic inflammatory myopathies; OR: odds ratio. BOLD text: statistically significant (P < 0.05).
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
